NFAT2-HDAC1信号通路促进胶质母细胞瘤恶性表型
该研究探讨NFAT2在胶质母细胞瘤(GBM)中的作用,通过数据库分析和胶质瘤干细胞(GSC)功能实验发现,NFAT2高表达与间质亚型及复发GBM相关并预测生存差;NFAT2通过调控HDAC1转录活性维持GSC恶性表型并促进间质分化,为GBM治疗提供潜在分子靶点。
要点
- NFAT2高表达与GBM间质亚型、复发及不良预后显著相关。
- NFAT2沉默抑制间质型GSC的侵袭和克隆形成,过表达促进肿瘤生长和间质分化。
- NFAT2通过调控HDAC1转录活性影响NF-κB乙酰化,维持GSC恶性表型。
核心结论
- NFAT2-HDAC1通路在维持GSC恶性表型和促进间质转化中起重要作用,可能成为GBM治疗靶点。
研究设计与样本
- 研究利用REMBRANDT和TCGA数据库及临床样本分析NFAT2表达与预后,并在胶质瘤干细胞中通过沉默或过表达NFAT2评估体外活力、侵袭、自我更新及体内致瘤性。
主要发现
- NFAT2高表达与间质亚型和复发GBM显著相关,并预测生存差。
- NFAT2沉默抑制间质型GSC富集球的体外侵袭和克隆形成及体内生长。
- NFAT2过表达促进GSC肿瘤生长和间质分化。
- TCGA数据库显示HDAC1表达与NFAT2显著相关,NFAT2调控HDAC1转录活性。
- 在NFAT2敲低GSC中恢复HDAC1可部分恢复肿瘤生长和间质表型;NFAT2和HDAC1缺失导致NF-κB超乙酰化,抑制NF-κB依赖的转录活性。
临床怎么用
- NFAT2-HDAC1通路可能作为GBM尤其是间质亚型的潜在治疗靶点,需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Deregulation of the nuclear factor of activated T cell (NFAT) pathway has been reported in several human cancers. Particularly, NFAT2 is involved in the malignant transformation of tumor cells and is identified as an oncogene. However, the role of NFAT2 in glioblastoma (GBM) is largely unknown. METHODS: The expression and prognostic value of NFAT2 were examined in the databases of the Repository of Molecular Brain Neoplasia Data and The Cancer Genome Atlas (TCGA) and clinical samples. The functional effects of silencing or overexpression of NFAT2 were evaluated in glioma stem cell (GSC) viability, invasion, and self-renewal in vitro and in tumorigenicity in vivo. The downstream target of NFAT2 was investigated. RESULTS: High NFAT2 expression was significantly associated with mesenchymal (MES) subtype and recurrent GBM and predicted poor survival. NFAT2 silencing inhibited the invasion and clonogenicity of MES GSC-enriched spheres in vitro and in vivo. NFAT2 overexpression promoted tumor growth and MES differentiation of GSCs. A TCGA database search showed that histone deacetylase 1 (HDAC1) expression was significantly correlated with that of NFAT2. NFAT2 regulates the transcriptional activity of HDAC1. Rescue of HDAC1 in NFAT2-knockdown GSCs partially restored tumor growth and MES phenotype. Loss of NFAT2 and HDAC1 expression resulted in hyperacetylation of nuclear factor-kappaB (NF-κB), which inhibits NF-κB-dependent transcriptional activity. CONCLUSION: Our findings suggest that the NFAT2-HDAC1 pathway might play an important role in the maintenance of the malignant phenotype and promote MES transition in GSCs, which provide potential molecular targets for the treatment of GBMs.
引用
- Song Y, Jiang Y, Tao D, et al. NFAT2-HDAC1 signaling contributes to the malignant phenotype of glioblastoma. Neuro Oncol. 2020. PMID: 31400279. doi:10.1093/neuonc/noz136
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。